The impact of competing risks on the observed rate of chronic hepatitis C progression

Gastroenterology

Volumn 127, Issue 3, 2004, Pages 749-755

  Kim, W Ray ^a   Poterucha, John J ^a   Benson, Joanne T ^a   Therneau, Terry M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; COMPUTER MODEL; DISEASE COURSE; FIBROSIS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOBILIARY SYSTEM; LIVER; LIVER CIRRHOSIS; MORTALITY; PANCREAS; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; SIMULATION; SURVIVAL;

EID: 4444356823     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.06.052     Document Type: Article

References (29)

1. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 Suppl 1 2002 S21 S29
2. L.B. Seeff Natural history of chronic hepatitis C Hepatology 36 Suppl 1 2002 S35 S46
3. A.J. Freeman, G.J. Dore, M.G. Law, M. Thorpe, J. Von Overbeck, A.R. Lloyd, G. Marinos, J.M. Kaldor Estimating progression to cirrhosis in chronic hepatitis C virus infection Hepatology 34 2001 809 816
4. M.J. Tong, N.S. el-Farra, A.R. Reikes, R.L. Co Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1995 1463 1466
5. M. Yano, H. Kumada, M. Kage, K. Ikeda, K. Shimamatsu, O. Inoue, E. Hashimoto, J.H. Lefkowitch, J. Ludwig, K. Okuda The long-term pathological evolution of chronic hepatitis C Hepatology 23 1996 1334 1340
6. F. Tremolada, C. Casarin, A. Alberti, C. Drago, A. Tagger, M.L. Ribero, G. Realdi Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis J Hepatol 16 1992 273 281
7. L. Serfaty, O. Chazouilleres, A. Poujol-Robert, L. Morand-Joubert, C. Dubois, Y. Chretien, R.E. Poupon, J.C. Petit, R. Poupon Risk factors for cirrhosis in patients with chronic hepatitis C virus infection results of a case-control study Hepatology 26 1997 776 779
8. F. Roudot-Thoraval, A. Bastie, J.M. Pawlotsky, D. Dhumeaux The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus Epidemiological factors affecting the severity of hepatitis C virus-related liver disease a French survey of 6,664 patients Hepatology 26 1997 485 490
9. F. Degos, C. Christidis, N. Ganne-Carrie, J.P. Farmachidi, C. Degott, C. Guettier, J.C. Trinchet, M. Beaugrand, S. Chevret Hepatitis C virus related cirrhosis time to occurrence of hepatocellular carcinoma and death Gut 47 2000 131 136
10. M. Wiese, F. Berr, M. Lafrenz, H. Porst, U. Oesen Low frequency of cirrhosis in a hepatitis c (genotype 1b) single-source outbreak in Germany a 20-year multicenter study Hepatology 32 2000 91 96
11. L.B. Seeff, Z. Buskell-Bales, E.C. Wright, S.J. Durako, H.J. Alter, F.L. Iber, F.B. Hollinger, G. Gitnick, R.G. Knodell, R.P. Perrillo The National Heart, Lung, and Blood Institute Study Group Long-term mortality after transfusion-associated non-A, non-B hepatitis N Engl J Med 327 1992 1906 1911
12. L.B. Seeff, R.N. Miller, C.S. Rabkin, Z. Buskell-Bales, K.D. Straley-Eason, B.L. Smoak, L.D. Johnson, S.R. Lee, E.L. Kaplan 45-year follow-up of hepatitis C virus infection in healthy young adults Ann Intern Med 132 2000 105 111
13. E. Kenny-Walsh Irish Hepatology Research Group Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin N Engl J Med 340 1999 1228 1233
14. T. Poynard, P. Bedossa, P. Opolon The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 1997 825 832
15. Y. Benhamou, V. Di Martino, M. Bochet, G. Colombet, V. Thibault, A. Liou, C. Katlama, T. Poynard MultivirC Group Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients impact of protease inhibitor therapy Hepatology 34 2001 283 287
16. M.V. Ragni, S.H. Belle Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection J Infect Dis 183 2001 1112 1115
17. C. Niederau, S. Lange, T. Heintges, A. Erhardt, M. Buschkamp, D. Hurter, M. Nawrocki, L. Kruska, F. Hensel, W. Petry, D. Haussinger Prognosis of chronic hepatitis C results of a large, prospective cohort study Hepatology 28 1998 1687 1695
18. E.R. Schiff Hepatitis C and alcohol Hepatology 26 Suppl 1 1997 39S 42S
19. T.E. Wiley, M. McCarthy, L. Breidi, T.J. Layden Impact of alcohol on the histological and clinical progression of hepatitis C infection Hepatology 28 1998 805 809
20. S.L. Cromie, P.J. Jenkins, D.S. Bowden, F.J. Dudley Chronic hepatitis C effect of alcohol on hepatitic activity and viral titre J Hepatol 25 1996 821 826
21. M. Geissler, A. Gesien, J.R. Wands Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids J Immunol 159 1997 5107 5113
22. T. Poynard, V. Ratziu, F. Charlotte, Z. Goodman, J. McHutchison, J. Albrecht Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C J Hepatol 34 2001 730 739
23. M. Oshita, N. Hayashi, A. Kasahara, H. Hagiwara, E. Mita, M. Naito, K. Katayama, H. Fusamoto, T. Kamada Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C Hepatology 20 1994 1115 1120
24. K.J. Rothman, S. Greenland Measures of disease frequency K.J. Rothman S. Greenland Modern epidemiology 1998 Lippincott-Raven Philadelphia, PA 29 46
25. T.A. Gooley, W. Leisenring, J. Crowley, B.E. Storer Estimation of failure probabilities in the presence of competing risks new representations of old estimators Stat Med 18 1999 695 706
26. R.A. Kyle, T.M. Therneau, S.V. Rajkumar, E.D. Remstein, J.R. Offord, D.R. Larson, M.F. Plevak, L.J. Melton III Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 102 2003 3759 3764
27. A.J. McCullough Obesity and its nurturing effect on hepatitis C Hepatology 38 2003 557 559
28. X. Wang, E. Quail, N.J. Hung, Y. Tan, H. Ye, R.H. Costa Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver Proc Natl Acad Sci U S A 98 2001 11468 11473
29. M. Wali, R.F. Harrison, P.J. Gow, D. Mutimer Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C Gut 51 2002 248 252